|
151 |
Details of Applicants approved under Production Linked Incentive (PLI) Scheme for Pharmaceuticals |
|
|
152 |
Message from Honorable Minister (C&F) on Swachhta Pakhwada During 1-15 September 2022 |
|
|
153 |
Message from Honorable MoS (C&F) on Swachhta Pakhwada During 1-15 September 2022 |
|
|
154 |
Invitation of Applications from eligible Category B Applicants under the revised guidelines of Production Link Incentive (PU) Scheme for Promoting Domestic Manufacturing of Medical Devices dated 18.8.2022 from 1st September 2022 to 31st October 2022 - reg |
|
|
155 |
Corrigendum-Hiring of Young Professionals in the Department of Pharmaceuticals on contract basis. |
|
|
156 |
Revised Guidelines for the Production Linked Incentive (PLI) Scheme for Promoting Domestic Manufacturing of Medical Devices |
|
|
157 |
Hiring of Young Professionals in the Department of Pharmaceuticals on contract basis - regarding |
|
|
158 |
List of Approved Applicants under Production Linked Incentive (PLI) Scheme for Bulk Drug Dated 8th August, 2022 |
|
|
159 |
Seeking the details of domestic manufacturers of the inputs required for manufacture of Vaccines and Biopharmaceuticals. |
|
|
160 |
Corrigendum of PLI Scheme for Bulk Drug- Dated 26th July, 2022 |
|
|
161 |
Invitation of applications for the eligible product Vitamin B1,through chemical synthesis route under Production Linked Incentive (PLI) Scheme for Bulk Drug |
|
|
162 |
Guidelines for the Scheme Strengthening of Pharmaceuticals Industry (SPI)- Notification of the modifications of the few clauses in the GLs - regarding |
|
|
163 |
Filling up the post of Director (Finance) in Bengal Chemicals & Pharmaceuticals Ltd.(BCPL) through PESB selection mode.- regarding |
|
|
164 |
O.M. dated 02.05.2022 to Central Procurement Agencies to exercise due diligence on the claims of the local manufacturers while proceeding for the procurement |
|
|
165 |
Seeking comments/views/ suggestions from Stakeholders on Framing of Recruitment Rules for the post of Staff Car Driver in Department of Pharmaceuticals - reg |
|
|
166 |
Guidelines on Pharmaceutical Innovation & Entrepreneurship |
|
|
167 |
FAQs on the Invitation of Tender for selection of Public Financial Institution (Government Company) for providing services of Project Management Consultant (PMC) for the Scheme 'Strengthening of Pharmaceuticals Industry' (SPI) |
|
|
168 |
Extension of timeline to submit proposal: Invitation of Tender for selection of Public Financial Institution (Government Company) for providing services of Project Management Consultant (PMC) for the Scheme Strengthening of Pharmaceuticals Industry (SPI) |
|
|
169 |
Approval accorded to the States under the scheme 'Promotion of Medical Devices Park' |
|
|
170 |
Awards to the leading Pharma and Medical Devices Industry playersIndia Pharma 2022 & India Medical Devices 2022-Extension of Date for invitation of Applications -reg |
|
|
171 |
Annual Report 2021-22 |
|
|
172 |
Invitation of Applications for the posts of Director of NIPER- Ahmedabad and NIPER-Raebareli |
|
|
173 |
Invitation of Applications under the PLI Scheme for Promotion of Domestic Manufacturing of critical Key Starting Materials(KSMs)/Drug Intermediates and Active Pharmaceuticals Ingredients (APIs) - extension till 30.04.2022 |
|
|
174 |
Notice: PPDS scheme for FY 21-22 - Selection of agencies for conducting studies (Long Term and Short Term) - reg. |
|
|
175 |
Portal for India Pharma and India Medical Device Awards |
|
|
176 |
Timeline Extension for filling applications under PLI Scheme for Promotion of Domestic Manufacturing of critical Key Starting Materials(KSMs)/Drug Intermediates and Active Pharmaceuticals Ingredients (APIs) upto 31.03.2022 |
|
|
177 |
Guidelines for the Scheme for Strengthening of Pharmaceuticals Industry (SPI) |
|
|
178 |
Guidelines regarding Awards to the leading Pharma and Medical Devices Industry players - India Pharma 2022 & India Medical Devices 2022. |
|
|
179 |
Notice regarding Awards to the leading Pharma and Medical Devices Industry players - India Pharma 2022 & India Medical Devices 2022 |
|
|
180 |
Public Notice dated 28.02.2022 :Inviting details of local manufacturers of specific Drugs -reg. |
|
|
181 |
List of approved applicants under PLI Scheme for Bulk Drug (Dated :20-01-2021) |
|
|
182 |
Public Notice dated 01.02.2022: Relaxation on Global Tender Enquiry (GTE) under Rule 161(iv) of General Financial Rules (GFRs) 2017 for procurement of Medical Devices - reg. |
|
|
183 |
Hiring of Technical Consultant for Pharmaceuticals and Medical Devices. |
|
|
184 |
Invitation of Applications under the Production Linked Incentive (PLI) Scheme for Promotion of Domestic Manufacturing of critical Key Starting Materials (KSMs)/Drug Intermediates and Active Pharmaceuticals Ingredients (APIs) in the Country |
|
|
185 |
List of approved applicants under PLI Scheme for Medical Devices |
|
|
186 |
Press Notes regarding Approvals accorded under PLI Scheme for Promotion of Domestic Manufacturing of critical Key Starting Materials (KSMs)/ Drug Intermediates and Active Pharmaceutical Ingredients (APIs) in the country. Dated: 9th December, 2021 |
|
|
187 |
Press Notes regarding Approval accorded under PLI Scheme for Promotion of Domestic Manufacturing of Medical Devices. Dated: 9th December, 2021 |
|
|
188 |
List of Approved Applicants under Production Linked Incentive (PLI) Scheme for Pharmaceuticals |
|
|
189 |
List of Approved Applicants under the the Production Linked Incentive (PLI) scheme for promotion of domestic manufacturing of critical Key Starting Materials (KSMs)/ Drug Intermediates (DIs)/ Active Pharmaceutical Ingredients (APIs) in India |
|
|
190 |
Inviting details of local manufacturers of specific medical devices/equipments |
|
|
191 |
Corrigendum- Invitation of Tender for selection of reputed empanelled agencies with Government of India for conducting studies and submission of report thereof -regarding. |
|
|
192 |
Press Release regarding Selection of applicants under the Production Linked Incentive (PLI) scheme for Pharmaceuticals |
|
|
193 |
Corrigendum- Invitation of Tender for selection of reputed empanelled agencies with Government of India for conducting studies and submission of report thereof -regarding. |
|
|
194 |
FAQ: Invitation of Tender for selection of reputed empanelled agencies with Government of India for conducting studies and submission of report thereof |
|
|
195 |
Corrigendum- Invitation of Tender for selection of reputed empanelled agencies with Government of India for conducting studies and submission of report thereof -regarding. |
|
|
196 |
Corrigendum- Invitation of Tender for selection of reputed empanelled agencies with Government of India for conducting studies and submission of report thereof -regarding. |
|
|
197 |
Corrigendum: R.F.P. for Short Term Study and Long Term Study -Invitation of Tender for selection of reputed empanelled agencies with Government of India for conducting studies and submission of report thereof. |
|
|
198 |
Regarding- Draft Policy to Catalyze Research & Development and Innovation in the Pharma - MedTech Sector in India |
|
|
199 |
Circulation of Draft Policy to Catalyze Research & Development and Innovation in the Pharma- MedTech Sector in India |
|
|
200 |
R.F.P. for Long Term Study- Invitation of Tender for selection of reputed empanelled agencies with Government of India for conducting studies and submission of report thereof. |
|
औषध विभाग
Department of
